HEALTH & LIFE SCIENCES INDUSTRY ANALYSIS

Welcome to our first ever ‘Shaw Report’ into the Health and Life Sciences (H&LS) industry which provides SME business leaders with a powerful benchmarking tool to aid their decision making.

‍

"IN THIS REPORT WE HAVE SEGMENTED 1,380 H&LS BUSINESSES WITH EARNINGS OF £1M+ BY SIZE AND SUBSECTOR TO TRACK THEIR PERFORMANCE, PROFITABILITY, DEBT LEVELS AND M&A ACTIVITY."

Rick Martignetti
Manager, Shaw & Co

‍

Larger blue-chip corporates have regular access to this type of analysis from investment banking advisers. However, it is our mission to provide SME business leaders with free access to the same market intelligence in a clear, concise and easy-to-use way.

This report will help you benchmark your performance relative to your competitors in the subsector in which you operate. It will also provide you with valuable insight regarding your relative creditworthiness and attractiveness from a M&A point of view.

‍

KEY FINDINGS

• Despite Covid-19, the average profit margins achievable within the industry range between 33% to 40%.
• 6% of companies generate 71% of turnover within the industry.
• Businesses with solid growth plans could borrow up to 4 times earnings (Ebitda).
• Competitive rivalry within the industry is high and we expect M&A activity to remain buoyant for the foreseeable future.

‍

DOWNLOAD

To download your free copy, simply click the image below. If you have any problems with the download, please contact Karl Blockwell.